Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 72

The DOI matches its Crossref record.

Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice

Barefield, David, Kumar, Mohit, Gorham, Joshua, Seidman, Jonathan G., Seidman, Christine E., de Tombe, Pieter P., Sadayappan, Sakthivel · 2015 · Journal of Molecular and Cellular Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yjmcc.2014.11.018

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 46

  1. Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study, Circulation, 92, 785, 10.1161/01.CIR.92.4.785 · DOI · Paper page
  2. Go, 2013, Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, e28, 10.1161/01.cir.0000441139.02102.80 · DOI · Paper page
  3. Morita, 2008, Shared genetic causes of cardiac hypertrophy in children and adults, N Engl J Med, 358, 1899, 10.1056/NEJMoa075463 · DOI · Paper page
  4. Harris, 2011, In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament, Circ Res, 108, 751, 10.1161/CIRCRESAHA.110.231670 · DOI · Paper page
  5. Watkins, 1995, Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy, Nat Genet, 11, 434, 10.1038/ng1295-434 · DOI · Paper page
  6. Bonne, 1995, Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy, Nat Genet, 11, 438, 10.1038/ng1295-438 · DOI · Paper page
  7. Niimura, 1998, Mutations in the gene for cardiac myosin-binding protein c and late-onset familial hypertrophic cardiomyopathy, N Engl J Med, 338, 1248, 10.1056/NEJM199804303381802 · DOI · Paper page
  8. Moolman, 2000, A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance, Circulation, 101, 1396, 10.1161/01.CIR.101.12.1396 · DOI
  9. Alcalai, 2008, Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics, J Cardiovasc Electrophysiol, 19, 104, 10.1111/j.1540-8167.2007.00965.x · DOI · Paper page
  10. Knöll, 2012, Myosin binding protein C: implications for signal-transduction, J Muscle Res Cell Motil, 33, 31, 10.1007/s10974-011-9281-6 · doi:10.1007/s10974-011-9281-6
  11. Marston, 2009, Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency, Circ Res, 105, 219, 10.1161/CIRCRESAHA.109.202440 · DOI · Paper page
  12. van Dijk, 2009, Cardiac myosin-binding protein c mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction, Circulation, 119, 1473, 10.1161/CIRCULATIONAHA.108.838672 · DOI · Paper page
  13. McConnell, 1999, Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice, J Clin Invest, 104, 1235, 10.1172/JCI7377 · DOI · Paper page
  14. Harris, 2002, Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice, Circ Res, 90, 594, 10.1161/01.RES.0000012222.70819.64 · DOI · Paper page
  15. Carrier, 2004, Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice, Cardiovasc Res, 63, 293, 10.1016/j.cardiores.2004.04.009 · DOI
  16. Vignier, 2009, Nonsense-mediated mRNA decay and ubiquitin–proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice, Circ Res, 105, 239, 10.1161/CIRCRESAHA.109.201251 · DOI · Paper page
  17. Cheng, 2013, Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere, Am J Physiol Heart Circ Physiol, 305, H52, 10.1152/ajpheart.00929.2012 · DOI
  18. Barefield, 2014, Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy, Am J Physiol Heart Circ Physiol, 306, H807, 10.1152/ajpheart.00913.2013 · DOI
  19. Kuster, 2014, MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25bp deletion mutation, Pflugers Arch, 466, 207, 10.1007/s00424-013-1417-7 · DOI
  20. Christodoulou, 2014, 5′RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy, J Clin Invest, 124, 1364, 10.1172/JCI70108 · DOI
  21. Dorn, 2014, Two strikes and you're out: gene–gene mutation interactions in HCM, Circ Res, 115, 208, 10.1161/CIRCRESAHA.114.304383 · DOI
  22. Blankenburg, 2014, Beta-myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations, Circ Res, 115, 227, 10.1161/CIRCRESAHA.115.303178 · DOI
  23. Najafi, 2014, Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice, Pflugers Arch
  24. Berul, 2001, Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant myosin-binding protein C gene, Circulation, 104, 2734, 10.1161/hc4701.099582 · doi:10.1161/hc4701.099582
  25. McConnell, 2001, Comparison of two murine models of familial hypertrophic cardiomyopathy, Circ Res, 88, 383, 10.1161/01.RES.88.4.383 · DOI
  26. Sadayappan, 2009, Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background, Circulation, 119, 1253, 10.1161/CIRCULATIONAHA.108.798983 · DOI
  27. Verma, 2012, Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB, Circulation, 126, 418, 10.1161/CIRCULATIONAHA.112.112185 · DOI · Paper page
  28. Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, 2002, 10.1093/nar/29.9.e45 · DOI · Paper page
  29. Christodoulou, 2011, Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease, Curr Protoc Mol Biol, 10.1002/0471142727.mb0412s94 · DOI
  30. Sadayappan, 2005, Cardiac myosin binding protein-C phosphorylation and cardiac function, Circ Res, 97, 1156, 10.1161/01.RES.0000190605.79013.4d · DOI · Paper page
  31. Barefield, 2010, Phosphorylation and function of cardiac myosin binding protein-C in health and disease, J Mol Cell Cardiol, 48, 866, 10.1016/j.yjmcc.2009.11.014 · DOI · Paper page
  32. Sadayappan, 2006, Cardiac myosin binding protein-C phosphorylation is cardioprotective, Proc Natl Acad Sci U S A, 103, 16918, 10.1073/pnas.0607069103 · DOI · Paper page
  33. Sadayappan, 2011, A critical function for Ser-282 in cardiac myosin binding protein-C phosphorylation and cardiac function, Circ Res, 109, 141, 10.1161/CIRCRESAHA.111.242560 · DOI
  34. Copeland, 2010, Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle, J Mol Cell Cardiol, 49, 1003, 10.1016/j.yjmcc.2010.09.007 · DOI
  35. Chandra, 1997, Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C, Biochemistry, 36, 13305, 10.1021/bi9710129 · DOI
  36. Frazier, 2011, Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy, Prog Pediatr Cardiol, 31, 29, 10.1016/j.ppedcard.2010.11.006 · DOI
  37. Tong, 2008, Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function, Circ Res, 103, 974, 10.1161/CIRCRESAHA.108.177683 · DOI · Paper page
  38. Chen, 2012, Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice, Circulation, 126, 1194, 10.1161/CIRCULATIONAHA.111.089219 · DOI
  39. Fraysse, 2012, Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice, J Mol Cell Cardiol, 52, 1299, 10.1016/j.yjmcc.2012.03.009 · DOI
  40. Mearini, 2008, The ubiquitin–proteasome system in cardiac dysfunction, Biochim Biophys, 1782, 749, 10.1016/j.bbadis.2008.06.009 · DOI
  41. Sorajja, 2000, The molecular genetics of hypertrophic cardiomyopathy: prognostic implications, Europace, 2, 4, 10.1053/eupc.1999.0067 · DOI
  42. Witayavanitkul, 2014, Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium, J Biol Chem, 289, 8818, 10.1074/jbc.M113.541128 · DOI
  43. Jeong, 2013, Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties, J Mol Cell Cardiol, 56, 44, 10.1016/j.yjmcc.2012.12.003 · DOI
  44. Patel, 2013, Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C, Front Physiol, 4, 336, 10.3389/fphys.2013.00336 · doi:10.3389/fphys.2013.00336
  45. Dhandapany, 2009, A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia, Nat Genet, 41, 187, 10.1038/ng.309 · DOI · Paper page
  46. Fatkin, 2014, Genetics and disease of ventricular muscle, Cold Spring Harb Perspect Med, 4, a021063, 10.1101/cshperspect.a021063 · DOI

Cited by

See all 72

Metadata

Authors
Barefield, D., Kumar, M., Gorham, J., Seidman, J. G., Seidman, C. E., de Tombe, P. P., & Sadayappan, S.
Venue
Journal of Molecular and Cellular Cardiology
Publisher
Elsevier BV
Published
2015-02
Volume
79
Pages
234-243
ISSN
0022-2828
Cited by
72
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Heart, Lung, and Blood Institute (R01HL-105826, K02HL-114749, HL-101297, HL-75494, P01HL62426)
  • American Heart Association (11PRE7240022, 14GRNT20490025)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. https://app.cochat.ai/papers/10.1016/j.yjmcc.2014.11.018
The paper
Barefield, D., Kumar, M., Gorham, J., Seidman, J. G., Seidman, C. E., de Tombe, P. P., & Sadayappan, S. (2015). Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2014.11.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.